A Simplified and Scalable Synthesis of Artesunate
Overview
Affiliations
Abstract: An efficient and economically viable approach for the large-scale conversion of artemisinin into the antimalarial frontline drug artesunate was developed. This advanced synthesis includes an NaBH-induced reduction, followed by an esterification with succinic anhydride under basic conditions. The entire conversion follows the principles of green chemistry, i.e., application of reusable solvents.
Graphical Abstract:
Artemisinin and Its Derivatives as Potential Anticancer Agents.
Wen L, Chan B, Qiu M, Leung P, Wong C Molecules. 2024; 29(16).
PMID: 39202965 PMC: 11356986. DOI: 10.3390/molecules29163886.
Vamvoukaki G, Antoniou A, Baltas M, Mouray E, Charneau S, Grellier P Antibiotics (Basel). 2024; 13(2).
PMID: 38391528 PMC: 10886162. DOI: 10.3390/antibiotics13020142.
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2.
Marchesi E, Gentili V, Bortolotti D, Preti L, Marchetti P, Cristofori V ACS Omega. 2023; 8(47):45078-45087.
PMID: 38046338 PMC: 10688034. DOI: 10.1021/acsomega.3c07034.
Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates.
Marchesi E, Perrone D, Navacchia M Pharmaceutics. 2023; 15(9).
PMID: 37765156 PMC: 10536797. DOI: 10.3390/pharmaceutics15092185.
Investigation of new ferrocenyl-artesunate derivatives as antiparasitics.
Munnik B, Kaschula C, Harding C, Chellan P Dalton Trans. 2023; 52(43):15786-15797.
PMID: 37681434 PMC: 10628858. DOI: 10.1039/d3dt02254d.